Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, Modena, Italy.
Internal Medicine Unit, University of Rome, Roma 1, Rome, Italy.
Intern Emerg Med. 2024 Nov;19(8):2105-2119. doi: 10.1007/s11739-024-03715-3. Epub 2024 Aug 29.
Non-invasive respiratory support, namely, non-invasive ventilation, continuous positive airway pressure, and high-flow nasal cannula, has been increasingly used worldwide to treat acute hypoxemic respiratory failure, giving the benefits of keeping spontaneous breathing preserved. In this scenario, monitoring and controlling respiratory drive could be helpful to avoid patient self-inflicted lung injury and promptly identify those patients that require an upgrade to invasive mechanical ventilation. In this review, we first describe the physiological components affecting respiratory drive to outline the risks associated with its hyperactivation. Further, we analyze and compare the leading strategies implemented for respiratory drive monitoring and discuss the sedative drugs and the non-pharmacological approaches used to modulate respiratory drive during non-invasive respiratory support. Refining the available techniques and rethinking our therapeutic and monitoring targets can help critical care physicians develop a personalized and minimally invasive approach.
无创性呼吸支持,即无创通气、持续气道正压通气和高流量鼻导管,已在全球范围内越来越多地用于治疗急性低氧性呼吸衰竭,保留自主呼吸的优势。在这种情况下,监测和控制呼吸驱动可以帮助避免患者自伤性肺损伤,并及时识别那些需要升级为有创机械通气的患者。在这篇综述中,我们首先描述了影响呼吸驱动的生理成分,以概述其过度激活所带来的风险。此外,我们分析和比较了用于呼吸驱动监测的主要策略,并讨论了在无创性呼吸支持期间用于调节呼吸驱动的镇静药物和非药物方法。改进现有的技术并重新思考我们的治疗和监测目标,可以帮助重症监护医生制定个性化和微创的治疗方法。